Schonfeld Strategic Advisors LLC boosted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 493.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,000 shares of the biotechnology company's stock after acquiring an additional 9,145 shares during the quarter. Schonfeld Strategic Advisors LLC's holdings in Axon Enterprise were worth $6,538,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. New Wave Wealth Advisors LLC acquired a new stake in Axon Enterprise in the fourth quarter worth about $40,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $45,000. Stonebridge Financial Group LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth $53,000. GPS Wealth Strategies Group LLC lifted its holdings in shares of Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock valued at $56,000 after buying an additional 40 shares during the period. Finally, Versant Capital Management Inc grew its holdings in Axon Enterprise by 4,750.0% during the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock worth $58,000 after acquiring an additional 95 shares during the period. Institutional investors own 79.08% of the company's stock.
Axon Enterprise Stock Up 1.3 %
Shares of Axon Enterprise stock opened at $621.10 on Friday. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a 50 day moving average price of $551.54 and a two-hundred day moving average price of $575.64. The stock has a market capitalization of $48.35 billion, a P/E ratio of 160.49, a PEG ratio of 5.17 and a beta of 1.13.
Analyst Ratings Changes
A number of brokerages have weighed in on AXON. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Needham & Company LLC reiterated a "buy" rating and set a $600.00 price target on shares of Axon Enterprise in a report on Wednesday, April 23rd. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Finally, TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target for the company. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $626.45.
View Our Latest Analysis on Axon Enterprise
Insider Activity at Axon Enterprise
In other news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. The trade was a 0.33 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by company insiders.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
